Del 1153
Del 1153 i serien Advances in Experimental Medicine and Biology
Medical Science and Research
Häftad, Engelska, 2020
1 419 kr
Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
It also discusses metastatic renal cell carcinoma – a global scourge with an extremely poor long-term survival prognosis, the course and sequelae of renal cell carcinoma, as well as advances in targeted molecular therapy with sunitinib, a receptor tyrosine kinase inhibitor.
Produktinformation
- Utgivningsdatum2020-08-14
- Mått178 x 254 x 13 mm
- Vikt244 g
- FormatHäftad
- SpråkEngelska
- SerieAdvances in Experimental Medicine and Biology
- Antal sidor115
- FörlagSpringer Nature Switzerland AG
- ISBN9783030190613